Davis's Drug Guide
datopotamab deruxtecan
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
da-toe-poe-tah-mab der-ux-tee-kan
Trade Name(s)
- Datroway
Ther. Class.
Pharm. Class.
monoclonal antibodies
enzyme inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Datopotamab Deruxtecan." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580129/9/datopotamab_deruxtecan.
Vallerand AHA, Sanoski CAC, . Datopotamab deruxtecan. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580129/9/datopotamab_deruxtecan. Accessed April 25, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Datopotamab deruxtecan. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580129/9/datopotamab_deruxtecan
Vallerand AHA, Sanoski CAC, . Datopotamab Deruxtecan [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 25]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580129/9/datopotamab_deruxtecan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - datopotamab deruxtecan
ID - 3580129
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580129/9/datopotamab_deruxtecan
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -
